Adarsh Shankar Selected Research

Intravenous Administration

9/2013

Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adarsh Shankar Research Topics

Disease

17	Neoplasms (Cancer) 09/2017 - 01/2012
6	Glioblastoma (Glioblastoma Multiforme) 09/2017 - 12/2013
5	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2014
4	Glioma (Gliomas) 01/2016 - 01/2012
3	Hypoxia (Hypoxemia) 01/2016 - 12/2015
3	Triple Negative Breast Neoplasms 01/2015 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2016
1	Hematoma 10/2018
1	Inflammation (Inflammations) 01/2017
1	Stroke (Strokes) 09/2013
1	Infarction (Infarctions) 09/2013
1	Brain Neoplasms (Brain Tumor) 07/2012
1	Vascular System Injuries 07/2012
1	Necrosis 07/2012
1	Demyelinating Diseases (Demyelinating Disease) 07/2012
1	Adenocarcinoma 12/2011
1	Prostatic Neoplasms (Prostate Cancer) 12/2011
1	Carcinoma (Carcinomatosis) 12/2011

Drug/Important Bio-Agent (IBA)

5	HET0016IBA 09/2017 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2013
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 01/2014
4	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 09/2017 - 01/2014
4	vatalanib (PTK787)IBA 09/2017 - 12/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2014
3	Therapeutic UsesIBA 01/2016 - 09/2013
3	IronIBA 11/2013 - 01/2012
2	CytokinesIBA 01/2017 - 01/2014
2	MelatoninIBA 01/2016 - 01/2014
2	Vascular Endothelial Growth Factor CIBA 01/2015 - 01/2014
2	erucylphosphocholineIBA 11/2013 - 01/2012
1	Periodic AcidIBA 09/2017
1	Laminin (Merosin)IBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Y 27632IBA 01/2016
1	ChromatinIBA 01/2016
1	Keratins (Keratin)IBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	rho-Associated KinasesIBA 01/2016
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 12/2015
1	CurcuminIBA 01/2015
1	von Willebrand FactorIBA 03/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 12/2013
1	plerixafor FDA Link 12/2013
1	Sunitinib (Sutent)FDA Link 12/2013
1	ferric oxide (iron oxide)IBA 11/2013
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 06/2013
1	Hematoxylin (Haematoxylon)IBA 07/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2012
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 07/2012
1	LectinsIBA 07/2012
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2012

Therapy/Procedure

6	Therapeutics 09/2017 - 01/2012
2	Aftercare (After-Treatment) 01/2016 - 07/2012
1	Ischemic Postconditioning 10/2018
1	Radiotherapy 01/2016
1	Traditional Medicine (Folk Remedies) 01/2015
1	Intravenous Administration 09/2013
1	Chemoprevention 12/2011